Work

Benefit of early-phase targeted, basket, and immune-based trials for patients with chemorefractory gastrointestinal (GI) cancers.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.e15700

Authors: Rajiv Agarwal, Nicholas Anthony Cangemi, Andrew S. Epstein, James J. Harding, Neil Howard Segal, Diane Lauren Reidy, David Michael Hyman, Leonard B. Saltz

Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2946873163

Cites:

Cited by:

Related to: 10